FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1276841000168104: Carbidopa and Levodopa 25 mg/250 mg (Actavis) (carbidopa 25 mg + levodopa 250 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3268091000168115 Carbidopa and Levodopa 25 mg/250 mg (Actavis) (carbidopa 25 mg + levodopa 250 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3268101000168113 Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet Is a Carbidopa and Levodopa 25 mg/250 mg (Actavis) true Inferred relationship Some
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet Is a levodopa 250 mg + carbidopa 25 mg tablet true Inferred relationship Some
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet Is a trade product unit of use true Inferred relationship Some
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet has manufactured dose form tablet true Inferred relationship Some
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet has unit of use tablet true Inferred relationship Some 1397786875
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet has intended active ingredient levodopa true Inferred relationship Some 1189274172
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet has Australian BoSS levodopa true Inferred relationship Some 1189274172
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet has Australian BoSS carbidopa true Inferred relationship Some 1397786874
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet has intended active ingredient carbidopa true Inferred relationship Some 1397786874

Inbound Relationships Type Active Source Characteristic Refinability Group
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet, 100 has TPUU True Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet Inferred relationship Some 1
Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet, 100, bottle has TPUU True Carbidopa and Levodopa 25 mg/250 mg (Actavis) tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start